Get Started with ixamBee
Start learning 50% faster. Sign in now
The USFDA has issued a form 483 with 10 observations after inspection of Sun Pharma's Halol facility. The unit, however, now has a low contribution to the company’s turnover. The Halol facility was classified ‘Official Action Indicated (OAI)’ in March 2020, and was awaiting re-inspection from the US regulator. Due to the pandemic related travel restrictions, the re-inspection got delayed, and now the USFDA has issued a form 483 with observations. Sun Pharma said that the US Food and Drugs Administration (USFDA) did a Good Manufacturing Practices (GMP) inspection of Sun Pharmaceutical Industries Halol facility in Gujarat from April 26 to May 9, 2022. The Company is preparing the response to the observations, which will be submitted to the US FDA within 15 business days.
Which of the following is not the part of right to freedom as enshrined in the Article 19 of the Constitution of India (As amended)?
The period of limitation for filing any suit (for which no period of limitation has been provided in Schedule of the Limitation Act) shall be:
As per the LLP Act where the Tribunal makes an order under section 60 sanctioning a compromise or an arrangement in respect of a limited liability partn...
Bar to further suit to a plaintiff is expressly provided under which section of CPC?
A voluntarily burns a valuable security belonging to Z intending to cause wrongful loss to Z. A has committed
What does ‘R’ in SARFAESI stands for?
Judges in the Court of Session are appointed by:
The Board shall, ________ of the receipt of a reference from the Adjudicating Authority for the recommendation of an insolvency professional who may...
What constitutes an assault under the Bharatiya Nyaya Sanhita?
Order made under section 144 of the Code of Criminal Procedure, 1973, shall not remain in force for more than ________ from the making thereof.
